4.6 Letter

Discontinuation of Eculizumab Treatment in Atypical Hemolytic Uremic Syndrome: An Update

Journal

AMERICAN JOURNAL OF KIDNEY DISEASES
Volume 66, Issue 1, Pages 172-173

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2015.04.010

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available